Predicting Patient-specific CRC Incidence from Polyp Prevalence
Posted 17 Jun, 2008 in Teaching Materials
Download (PDF)
| Contributor(s) | Eric Sherer e-Enterprise Center, Purdue University; VA CoE on Implementing Evidence-based Practice |
|---|---|
| Abstract |
![]() Our goals are to
It is then shown how the model, tuned to both polyp and CRC prevalence, can be used to refine predictions of CRC incidence based on the results of colonoscopies rather than demographics alone. |
| Credits | Eric Sherer, e-Enterprise Center, Purdue University; Veteran's Administration CoE on Implementing Evidence-based Practice; Indiana University Center for Health Services and Outcomes Research; Regenstrief Institute, Inc. Seza Orcun, e-Enterprise Center, Purdue University Ann Rundell, Biomedical Engineering, Purdue University Doraiswami Ramkrishna, Chemical Engineering, Purdue University |
| Cite this work | If you reference this work in a publication, please cite as follows: |
| Tags |
Seminal work on CRC incidence modeling argued that the slope of the linear log-log CRC incidence with age implies that 6 or 7 somatic mutations are required for transformation to CRC. Subsequent modeling efforts have built on this theme by using models of linear, sequential transformations for predicting CRC incidence in the population in general and specific demographic groups. These random mutation models rarely explicitly account for the intermediate adenoma stages in the adenoma to carcinoma sequence.